Atlas Trials

Lenalidomide in Combination With CHOP in Patients With Untreated PTCL

Clinical trial NCT04423926 · UNKNOWN

Trial details

NCT number
NCT04423926
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
PTCL, NOSAITLALK- ALCLPhase III-IV ALK+ ALCLEATL
Start date
2020-06-10
Primary completion
2022-12-31
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.